Jeffrey Stoss - Molecule Holdings Chief Officer

All Insiders . USA . 
Stock . Molecule Holdings . Stakeholders . Insider . Jeffrey Stoss
EVRRF Stock  USD 0  0.00  0.00%   

Insider

Jeffrey Stoss is Chief Officer of Molecule Holdings
Phone613-809-1814
Webhttps://www.molecule.ca

Molecule Holdings Management Efficiency

The company has return on total asset (ROA) of (0.4066) % which means that it has lost $0.4066 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.8843) %, meaning that it generated substantial loss on money invested by shareholders. Molecule Holdings' management efficiency ratios could be used to measure how well Molecule Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
Molecule Holdings has accumulated 817.09 K in total debt with debt to equity ratio (D/E) of 1.37, which is about average as compared to similar companies. Molecule Holdings has a current ratio of 0.3, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Molecule Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Molecule Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Molecule Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Molecule to invest in growth at high rates of return. When we think about Molecule Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Sarah PybusAtlas Corp
45
Michael JDGCM Grosvenor
61
Francis IdehenGCM Grosvenor
46
David BrennerPureCycle Technologies
N/A
Frederick JDGCM Grosvenor
45
Lilly JDGCM Grosvenor
N/A
Byron BBAPureCycle Technologies
61
Michael OtworthPureCycle Technologies
N/A
Burke JDGCM Grosvenor
N/A
Peter CurtisAtlas Corp
65
Chris TalarekPureCycle Technologies
N/A
Amy ClarkPureCycle Technologies
N/A
Ivaldo CPAGCM Grosvenor
N/A
Michael DeePureCycle Technologies
67
Torsten PedersenAtlas Corp
53
Gabrielle SmithAtlas Corp
N/A
Marilyn JDAtlas Corp
N/A
John LipmanPureCycle Technologies
47
Matt CripePureCycle Technologies
N/A
Gordon CPAPureCycle Technologies
70
Graham TalbotAtlas Corp
58
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. Molecule Holdings is traded on OTC Exchange in the United States. Molecule Holdings [EVRRF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity-10.88
Return On Asset-0.41

Molecule Holdings Leadership Team

Elected by the shareholders, the Molecule Holdings' board of directors comprises two types of representatives: Molecule Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Molecule. The board's role is to monitor Molecule Holdings' management team and ensure that shareholders' interests are well served. Molecule Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Molecule Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Stoss, Chief Officer
Becky Griffin, Chief Officer
Tiago Zamponi, Head Sales
David Reingold, Pres CEO
Andre BComm, CoFounder Chairman
Amy Proulx, CoFounder Director
Philip Waddington, COO Director

Molecule Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Molecule Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-10.88
Return On Asset-0.41
Profit Margin(2.43) %
Operating Margin(2.15) %
Current Valuation5.39 M
Shares Outstanding97.78 M
Shares Owned By Insiders16.52 %
Price To Earning(2.27) X
Price To Book12.35 X
Price To Sales0.0001 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Molecule Pink Sheet

Molecule Holdings financial ratios help investors to determine whether Molecule Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecule with respect to the benefits of owning Molecule Holdings security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY